Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evening vs Morning Polypill Utilization Study
NL-OMON37659Active, not recruiting
- Sponsor
- University Medical Center Utrecht
- Start
- Aug 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of aspirin and ulinastatin in cardiac morbidity, dyslipidemia and hypertension (HTN) (3 arms), sponsored by University Medical Center Utrecht. Primary endpoints: Difference in LDL cholesterol between treatment regimens and Difference in mean 24-hour ambulatory systolic blood pressure between treatment regimens. Started Aug 2012; status: active, not recruiting.
02
Drugs
aspirinulinastatin
03
Conditions
cardiac morbiditydyslipidemiahypertension (HTN)
Beyond the preview
Go deeper on NL-OMON37659.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37659.